Life Pro Asset Management Zoetis Inc. Transaction History

Life Pro Asset Management

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$189.29 - $209.69 $414,355 - $459,011	-2,189 Closed	0 $0
Q2 2021 Aug 10, 2021	SELL	$155.9 - $187.99 $59,865 - $72,188	-384 Reduced 14.92%	2,189 $408,000
Q1 2021 Apr 28, 2021	SELL	$144.0 - $169.39 $4.01 Million - $4.72 Million	-27,846 Reduced 91.54%	2,573 $405,000
Q4 2020 Feb 08, 2021	BUY	$157.07 - $174.35 $649,641 - $721,111	4,136 Added 15.74%	30,419 $5.03 Million
Q3 2020 Jan 06, 2021	BUY	$137.1 - $165.37 $649,442 - $783,357	4,737 Added 21.99%	26,283 $4.35 Million
Q2 2020 Jan 06, 2021	BUY	$111.92 - $142.53 $2.41 Million - $3.07 Million	21,546 New	21,546 $2.95 Million

1,957

412M

1.02M

1.09M

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $82.7B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

Get notified when there are updates to the investment portfolio of Life Pro Asset Management, based on Form 13F filings with the SEC.

Stay updated on Life Pro Asset Management with notifications on news.